Skip to main content
OpenTrials
Completed

NCT Number: NCT01444703

Comparison of Licorice Versus Sugar-water Gargle for Prevention of Postoperative Sore Throat and Postextubation Coughing

The investigators propose to test the hypothesis that pre-operative gargling with licorice reduces the incidence of sore throat in rest after intubation with double-lumen endotracheal tubes compared to placebo after surgery through the first four post-extubation hours.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year–90 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Universitätsklinik für Anästhesie, Intensivmedizin und Schmerztherapie an der medizinischen Universität Wien

Vienna, Austria

About this study

Patients will be premedicated with up to 7.5 mg p.o. midazolam, per routine. They will be told that the study involves two different solutions for prevention of post-extubation sore throat.

Patients will be randomly assigned to gargle 5 minutes before induction of general anesthesia with: 1) licorice (0.5 g); or, 2) sugar (5 g). Randomization will be based on a computer-generated table of random numbers. Licorice or sugar (placebo) will be diluted in 30 ml water and filled in a small bottle by an independent apothecary of our university. All bottles will look similar and will not be opened until just before use. Investigator and patient will be blinded to the preparation used for gargle. Patients will be asked to gargle for two minutes, but not to swallow the solution.

General anesthesia will be induced with fentanyl ≈3 µg/kg, propofol ≈1.5 mg/kg, and rocuronium ≈0.6 mg/kg. Complete muscle relaxation will be confirmed by absence of palpable twitches in response to supra-maximal train-of-four stimulation of the ulnar nerve at the wrist. The trachea will then be intubated as gentle as possible. Intubation will be attempted with a Macintosh laryngoscope, but the anesthesiologists may subsequently use any other intubation equipment as necessary. Initial tube size will be 37 cm left in women and 39 cm left for men; however, other sizes can be used if clinically necessary. Endotracheal tube cuffs will be inflated with air to 20-25 mmHg as necessary to maintain an adequate seal.

General anesthesia will be primarily be maintained with sevoflurane. Patients lungs will be ventilated with O2 in air, usually with an inspired oxygen fraction (FiO2) of ≈40%. However, additional oxygen will be provided as clinically necessary, especially during one-lung ventilation. End-tidal CO2 will be maintained between 32 and 35 mmHg as clinically practical. Deep of anesthesia will be monitored by using bispectral index BIS, kept between 40 and 50. Small amounts of opioid will be permitted during surgery and in preparation for extubation. At the end of surgery, an intercostal plexus block -using up to 20 ml Ropivacaine 0.1% - will be performed by the surgeons. 1000 mg paracetamol will be given intravenously ten minutes before end of surgery. Post operative pain will be treated with fractional piritramid (Dipidolor) 3 mg IV as required.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Thoracic surgery with anticipated use of a double-lumen endotracheal tube;
  • Anticipated extubation in the operating room;
  • ASA Physical Status 1-3;
  • Age 18- 90

Exclusion criteria

  • Tracheal pathology, including tracheostomy;
  • Surgery within the previous four weeks;
  • Upper-respiratory tract infection;
  • BMI higher exceeding 40 kg/m2;
  • Known or suspected allergy to licorice;
  • Use of non-steroidal anti-inflammatory drug medication within 24 hours;
  • Chronic opioid use;
  • Preoperative pain ≥ 2 on an 11-point Likert scale (0 = no pain; 10 = worst pain);
  • Known or suspected difficult airway.

Treatment and study plan

licorice solution

Other

licorice (0.5 g)

sugar solution

Other

sugar (5 g).

Primary outcomes

  1. sore throat in rest after intubation

    Time frame: up to 4 hours post-extubation

    We propose to test the hypothesis that pre-operative gargling with licorice reduces the incidence of sore throat in rest after intubation with double-lumen endotracheal tubes compared to placebo after surgery through the first four post-extubation hours.

Secondary outcomes

  1. post-extubation coughing

    Time frame: up to four hours post-extubation

    Pre-operative gargling with licorice reduces sore throat pain during the initial postoperative day. Pre-operative gargling with licorice reduces the incidence of post-extubation coughing.

  2. amount of coughing

    Time frame: 24 hours post operative

    Pre-operative gargling with licorice reduces the amount of coughing during the remainder of the first postoperative day.

  3. sore throat in rest

    Time frame: first 24 hours after surgrey

    Pre-operative gargling with licorice reduces the incidence of sore throat in rest and during swallowing within the first 24 hours

  4. incidence of sore throat during swallowing

    Time frame: first 24 hours after surgery

    Pre-operative gargling with licorice reduces the incidence of sore throat in rest and during swallowing within the first 24 hours

Sponsors and collaborators

Lead sponsor

The Cleveland Clinic

Other

Registry information

Official study title

Randomized, Double-blind Comparison of Licorice Versus Sugar-water Gargle for Prevention of Postoperative Sore Throat and Postextubation Coughing

Important dates

Study start
2010
Primary completion
2011
Study completion
2011
First posted
Oct 3, 2011
Registry last updated
Jul 20, 2016

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.